Pharmachemie B.V.
FDA Approved Drugs

Pharmachemie B.V.

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued RX
  • Total Records 23
  • Latest Approval Date Feb 27, 2012
  • Data Source FDA
  • First Approval Date May 21, 1990
All
23
View
Discontinued
14
View
RX
9
View
Company Overview

Company

Pharmachemie B.V.

Country

Netherlands

Website

Visit Website

Email

pch.servicedesk@tevanederland.com

Social Profiles

Company Snapshot

Pharmachemie B.V.

Swensweg 5. P.O. Box 552. 2003 RN Haarlem

Netherlands

www.tevapharmachemie.com/ pch.servicedesk@tevanederland.com View on Map
FDA Approved Drug Records ( 23 records )
2007
13 Dec
Discontinued Application: 65201

Drug Name

BLEOMYCIN SULFATE

Product Number

1

Dosage Form

-

Strength

EQ 15 UNITS BASE/VIAL

Approval Date

2007-12-13

65201 / 1

Active Ingredient

BLEOMYCIN SULFATE

Application Number

65201

Product Number

1

Dosage Form

-

Strength

EQ 15 UNITS BASE/VIAL

Approval Date

2007-12-13

Regulatory Status

Discontinued

2004
14 Oct
RX Application: 77269

Drug Name

CARBOPLATIN

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2004-10-14

77269 / 1

Active Ingredient

CARBOPLATIN

Application Number

77269

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2004-10-14

Regulatory Status

RX

2004
14 Oct
RX Application: 77269

Drug Name

CARBOPLATIN

Product Number

2

Dosage Form

-

Strength

150MG/15ML (10MG/ML)

Approval Date

2004-10-14

77269 / 2

Active Ingredient

CARBOPLATIN

Application Number

77269

Product Number

2

Dosage Form

-

Strength

150MG/15ML (10MG/ML)

Approval Date

2004-10-14

Regulatory Status

RX

2004
14 Oct
RX Application: 77269

Drug Name

CARBOPLATIN

Product Number

3

Dosage Form

-

Strength

450MG/45ML (10MG/ML)

Approval Date

2004-10-14

77269 / 3

Active Ingredient

CARBOPLATIN

Application Number

77269

Product Number

3

Dosage Form

-

Strength

450MG/45ML (10MG/ML)

Approval Date

2004-10-14

Regulatory Status

RX

2007
28 Dec
RX Application: 77269

Drug Name

CARBOPLATIN

Product Number

4

Dosage Form

-

Strength

600MG/60ML (10MG/ML)

Approval Date

2007-12-28

77269 / 4

Active Ingredient

CARBOPLATIN

Application Number

77269

Product Number

4

Dosage Form

-

Strength

600MG/60ML (10MG/ML)

Approval Date

2007-12-28

Regulatory Status

RX

2009
25 Feb
Discontinued Application: 77679

Drug Name

CARBOPLATIN

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2009-02-25

77679 / 1

Active Ingredient

CARBOPLATIN

Application Number

77679

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2009-02-25

Regulatory Status

Discontinued

2009
25 Feb
Discontinued Application: 77679

Drug Name

CARBOPLATIN

Product Number

2

Dosage Form

-

Strength

150MG/15ML (10MG/ML)

Approval Date

2009-02-25

77679 / 2

Active Ingredient

CARBOPLATIN

Application Number

77679

Product Number

2

Dosage Form

-

Strength

150MG/15ML (10MG/ML)

Approval Date

2009-02-25

Regulatory Status

Discontinued

2009
25 Feb
Discontinued Application: 77679

Drug Name

CARBOPLATIN

Product Number

3

Dosage Form

-

Strength

450MG/45ML (10MG/ML)

Approval Date

2009-02-25

77679 / 3

Active Ingredient

CARBOPLATIN

Application Number

77679

Product Number

3

Dosage Form

-

Strength

450MG/45ML (10MG/ML)

Approval Date

2009-02-25

Regulatory Status

Discontinued

2000
16 May
RX Application: 74656

Drug Name

CISPLATIN

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2000-05-16

74656 / 1

Active Ingredient

CISPLATIN

Application Number

74656

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2000-05-16

Regulatory Status

RX

1990
21 May
Discontinued Application: 63097

Drug Name

DOXORUBICIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG/VIAL

Approval Date

1990-05-21

63097 / 1

Active Ingredient

DOXORUBICIN HYDROCHLORIDE

Application Number

63097

Product Number

1

Dosage Form

-

Strength

10MG/VIAL

Approval Date

1990-05-21

Regulatory Status

Discontinued

1990
21 May
Discontinued Application: 63097

Drug Name

DOXORUBICIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

20MG/VIAL

Approval Date

1990-05-21

63097 / 2

Active Ingredient

DOXORUBICIN HYDROCHLORIDE

Application Number

63097

Product Number

2

Dosage Form

-

Strength

20MG/VIAL

Approval Date

1990-05-21

Regulatory Status

Discontinued

1990
21 May
Discontinued Application: 63097

Drug Name

DOXORUBICIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

50MG/VIAL

Approval Date

1990-05-21

63097 / 3

Active Ingredient

DOXORUBICIN HYDROCHLORIDE

Application Number

63097

Product Number

3

Dosage Form

-

Strength

50MG/VIAL

Approval Date

1990-05-21

Regulatory Status

Discontinued

1995
28 Feb
Discontinued Application: 63336

Drug Name

DOXORUBICIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2MG/ML

Approval Date

1995-02-28

63336 / 1

Active Ingredient

DOXORUBICIN HYDROCHLORIDE

Application Number

63336

Product Number

1

Dosage Form

-

Strength

2MG/ML

Approval Date

1995-02-28

Regulatory Status

Discontinued

1995
28 Feb
Discontinued Application: 63336

Drug Name

DOXORUBICIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

200MG/100ML

Approval Date

1995-02-28

63336 / 4

Active Ingredient

DOXORUBICIN HYDROCHLORIDE

Application Number

63336

Product Number

4

Dosage Form

-

Strength

200MG/100ML

Approval Date

1995-02-28

Regulatory Status

Discontinued

1996
22 Feb
Discontinued Application: 74227

Drug Name

ETOPOSIDE

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

1996-02-22

74227 / 1

Active Ingredient

ETOPOSIDE

Application Number

74227

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

1996-02-22

Regulatory Status

Discontinued

1999
15 Dec
Discontinued Application: 40262

Drug Name

LEUCOVORIN CALCIUM

Product Number

1

Dosage Form

-

Strength

EQ 350MG BASE/VIAL

Approval Date

1999-12-15

40262 / 1

Active Ingredient

LEUCOVORIN CALCIUM

Application Number

40262

Product Number

1

Dosage Form

-

Strength

EQ 350MG BASE/VIAL

Approval Date

1999-12-15

Regulatory Status

Discontinued

1997
28 Mar
Discontinued Application: 73099

Drug Name

LEUCOVORIN CALCIUM

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

1997-03-28

73099 / 1

Active Ingredient

LEUCOVORIN CALCIUM

Application Number

73099

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

1997-03-28

Regulatory Status

Discontinued

1997
28 Mar
Discontinued Application: 73101

Drug Name

LEUCOVORIN CALCIUM

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

1997-03-28

73101 / 1

Active Ingredient

LEUCOVORIN CALCIUM

Application Number

73101

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

1997-03-28

Regulatory Status

Discontinued

2010
11 Jan
RX Application: 40843

Drug Name

METHOTREXATE SODIUM PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/40ML (EQ 25MG BASE/ML)

Approval Date

2010-01-11

40843 / 1

Active Ingredient

METHOTREXATE SODIUM

Application Number

40843

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/40ML (EQ 25MG BASE/ML)

Approval Date

2010-01-11

Regulatory Status

RX

2010
11 Jan
RX Application: 40843

Drug Name

METHOTREXATE SODIUM PRESERVATIVE FREE

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE/2ML (EQ 25MG BASE/ML)

Approval Date

2010-01-11

40843 / 2

Active Ingredient

METHOTREXATE SODIUM

Application Number

40843

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE/2ML (EQ 25MG BASE/ML)

Approval Date

2010-01-11

Regulatory Status

RX

2012
27 Feb
RX Application: 40843

Drug Name

METHOTREXATE SODIUM PRESERVATIVE FREE

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE/4ML (EQ 25MG BASE/ML)

Approval Date

2012-02-27

40843 / 3

Active Ingredient

METHOTREXATE SODIUM

Application Number

40843

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE/4ML (EQ 25MG BASE/ML)

Approval Date

2012-02-27

Regulatory Status

RX

2010
11 Jan
RX Application: 40843

Drug Name

METHOTREXATE SODIUM PRESERVATIVE FREE

Product Number

4

Dosage Form

-

Strength

EQ 250MG BASE/10ML (EQ 25MG BASE/ML)

Approval Date

2010-01-11

40843 / 4

Active Ingredient

METHOTREXATE SODIUM

Application Number

40843

Product Number

4

Dosage Form

-

Strength

EQ 250MG BASE/10ML (EQ 25MG BASE/ML)

Approval Date

2010-01-11

Regulatory Status

RX

2003
31 Mar
Discontinued Application: 74539

Drug Name

TAMOXIFEN CITRATE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2003-03-31

74539 / 1

Active Ingredient

TAMOXIFEN CITRATE

Application Number

74539

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2003-03-31

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    6 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    23 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
23 total
  • Discontinued
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BLEOMYCIN SULFATE

Application Number

65201

Product Number

1

Active Ingredient

BLEOMYCIN SULFATE

Dosage Form

-

Strength

EQ 15 UNITS BASE/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit